Ghana Commissions
World's Largest Calcined Clay Cement Plant
at Tema Free Zones.
President John Dramani Mahama officially commissioned the $110 million LC3 facility at the Tema Free Zones Enclave on March 5, 2026 - a landmark moment for Ghana's industrial policy, green economy ambitions and the entire African continent's approach to sustainable construction materials.
A National Milestone for Sustainable Industrialization.
The commissioning ceremony marked a significant moment in Ghana's industrial history. The plant, built with support from international partners and local engineering expertise, positions Tema as the continent's flagship LC3 hub.
We continue to document the operational, environmental and economic impact of this investment as the facility ramps to full output.
Inauguration Gallery
Showing 12 photos. Full gallery available on request.
Request Full Photo PackEarlier Milestones & Announcements.
CBI Ghana Secures Long-Term Cement Supply Agreement with Ghana Highway Authority for the Eastern Corridor Road Programme
Supacem LC3 formally selected as the preferred cement specification for Phase 2 of the Eastern Corridor road development, covering 340km of trunk roads across Eastern and Volta regions.
Norfund Confirms Strategic Investment in CBI Ghana's LC3 Expansion Programme
Norwegian development finance institution Norfund formalises its equity participation in CBI Ghana, backing the expansion of the Tema plant's calcined clay production capacity to 400,000 tonnes annually.
Ghana Standards Authority Formally Certifies Supacem LC3 as Ghana's Seventh Cement Type
Following an 18-month testing and consultation process with KNUST, CSIR and EPFL, the GSA issues the world's first national level LC3 standard certification to CBI Ghana's Supacem product line.
CBI Ghana Signs Technical Collaboration MOU with Heidelberg Materials and EPFL for Ongoing LC3 R&D
The memorandum of understanding formalises CBI Ghana's position as the primary commercial research partner in the global LC3 technology consortium, funding joint publication and field trial programmes through 2028.
Press, Media & Investor Enquiries.
For media accreditation, high-resolution images, executive interviews or investor briefing requests, please contact our corporate communications team.